US FDA Gives Directions On Navigating Generic 180-Day Exclusivity Maze
Draft guidance sums up agency’s policies for determining exclusivity, clarifies when the clock starts for failure to market.

Draft guidance sums up agency’s policies for determining exclusivity, clarifies when the clock starts for failure to market.